Literature DB >> 6017558

Sarcoidosis: clinical features and management.

L E Siltzbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6017558     DOI: 10.1016/s0025-7125(16)33069-3

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  20 in total

1.  Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors:  Helen S Te; Lucas Campbell; Saima Chohan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

2.  Sixteen cases of uveitis associated with sarcoidosis.

Authors:  M F Bienfait; G S Baarsma
Journal:  Int Ophthalmol       Date:  1986-12       Impact factor: 2.031

3.  Therapy of sarcoidosis initiated with alternate-day prednisone.

Authors:  J N Sheagren; H B Simon; R R Rich
Journal:  J Natl Med Assoc       Date:  1973-09       Impact factor: 1.798

4.  The treatment of sarcoidosis.

Authors:  H L Israel
Journal:  Postgrad Med J       Date:  1970-08       Impact factor: 2.401

5.  Sarcoidosis of the pancreas.

Authors:  H Chaun; D M King; J P Gofton; W H Sutherland; A Bogoch
Journal:  Am J Dig Dis       Date:  1972-08

6.  The epidemiology of sarcoidosis.

Authors:  G Hall; P Naish; O P Sharma; W Doe; D G James
Journal:  Postgrad Med J       Date:  1969-04       Impact factor: 2.401

Review 7.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

8.  Mediastinal widening and miliary chest radiograph pattern in a middle aged man: could it be sarcoidosis?

Authors:  Clementine Bostantzoglou; Konstantinos Samitas; Charalampos Gkogkou; Eleftherios Zervas; Mina Gaga
Journal:  BMJ Case Rep       Date:  2014-07-17

9.  Anchoring fibrils. A new connective tissue structure in fibrotic lung disease.

Authors:  O Kawanami; V J Ferrans; W C Roberts; R G Crystal; J D Fulmer
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

10.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.